Regnante Keith
CHIEF FINANCIAL OFFICER
CIK: 1682068
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | Keros Therapeutics, Inc. (KROS) | S | 4,739 | $16.35 | $77,482.65 | View Details Filing |
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | Keros Therapeutics, Inc. (KROS) | S | 4,739 | $16.35 | $77,482.65 | View Details Filing |